ANTAGONIST OF 5HT3 RECEPTORS ZOFRAN (ONDA NSETRON) IN PREVENTION OF NAUSEA AND VOMITING IN CANCER-PATIENTS ON CYTOSTATIC TREATMENT

Authors
PEREVODCHIKOVA NI VOLKOVA MA GORBUNOVA VA MANZYUK LV MARENICH AF SMIRNOVA NB
Citation
Ni. Perevodchikova et al., ANTAGONIST OF 5HT3 RECEPTORS ZOFRAN (ONDA NSETRON) IN PREVENTION OF NAUSEA AND VOMITING IN CANCER-PATIENTS ON CYTOSTATIC TREATMENT, Terapevticeskij arhiv, 68(2), 1996, pp. 30-34
Citations number
7
Categorie Soggetti
Medicine, General & Internal
Journal title
Terapevticeskij arhiv → ACNP
ISSN journal
00403660
Volume
68
Issue
2
Year of publication
1996
Pages
30 - 34
Database
ISI
SICI code
0040-3660(1996)68:2<30:AO5RZ(>2.0.ZU;2-U
Abstract
The authors describe regimens of zofran application convenient in onco logical practice to prevent nausea and vomiting in patients receiving cytostatic drugs. It is well tolerated and low toxic.